Related Experiment Videos
Vasodilatory action of carvedilol
G Sponer1, K Strein, W Bartsch
1Department of Experimental Cardiovascular Research, Boehringer Mannheim GmbH, Germany.
Journal of Cardiovascular Pharmacology
|January 1, 1992
Summary
Carvedilol offers dual action, combining beta-blockade and vasodilation. This unique profile effectively treats hemodynamic disorders by reducing vascular resistance and sympathetic tone.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
Background:
- Carvedilol is a dual-acting pharmaceutical agent.
- It exhibits both beta-blockade and vasodilation properties within a similar dosage range.
Purpose of the Study:
- To elucidate the dual mechanisms of carvedilol.
- To understand its role in treating cardiovascular conditions.
Main Methods:
- Review of carvedilol's pharmacological actions.
- Analysis of its effects on vascular resistance and blood pressure.
Main Results:
- Vasodilation is primarily mediated by alpha 1-adrenoceptor blockade.
- At higher concentrations, carvedilol shows calcium channel blocking-like effects, enhancing organ blood flow.
- Beta-blocking doses reduce systemic and regional vascular resistance.
Conclusions:
- Carvedilol's dual action is beneficial for hemodynamic disorders.
- Its profile supports treatment for hypertension, coronary artery disease, and heart failure.